Intervention

osimertinib

ClinicalTrials.gov intervention label

Clinical trials12
Recruiting2
Common conditions25
Lead sponsors shown8

Clinical trials

12 shown
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainNCT06741085 · 2024-12-13
RECRUITING
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibNCT04486833 · 2021-09-03
RECRUITING
A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.NCT05834348 · 2023-06-23
COMPLETED
Osimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCNCT05215951 · 2022-01-19
TERMINATED
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCNCT05153408 · 2022-01-13
TERMINATED
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCNCT04862780 · 2021-06-29
TERMINATED
Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior OsimertinibNCT03778229 · 2019-01-09
ACTIVE_NOT_RECRUITING
First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung CancerNCT03804580 · 2018-12-01
UNKNOWN
A Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNCT03434418 · 2018-06-30
COMPLETED
Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLCNCT03133234 · 2017-05-23
COMPLETED
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung CancersNCT02803203 · 2016-06-29
COMPLETED
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With OsimertinibNCT02759835 · 2016-04-13
COMPLETED

Common conditions

Carcinoma3Adenocarcinoma2Antineoplastic Agents2Bronchial Neoplasms2Carcinoma, Bronchogenic2Carcinoma, Non-Small-Cell Lung2EGF-R Positive Non-Small Cell Lung Cancer2EGFR Activating Mutation2EGFR C797S2EGFR Exon 19 Deletion2EGFR Gene Mutation2EGFR L858R2EGFR Mutation Resulting in Tyrosine Kinase Inhibitor Resistance2Lung Cancer2Lung Diseases2Lung Neoplasms2Neoplasms2Neoplasms by Histologic Type2Neoplasms by Site2Neoplasms, Nerve Tissue2Non Small Cell Lung Cancer2Non-small Cell Lung Cancer2Protein Kinase Inhibitors2Respiratory Tract Neoplasms2Thoracic Neoplasms2

Trial status mix

COMPLETED5
TERMINATED3
RECRUITING2
ACTIVE_NOT_RECRUITING1
UNKNOWN1

Phase mix

PHASE28
PHASE14

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.